Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. PTC Therapeutics Inc shares valued at $42,114 were sold by Golden Lee Scott on Apr 02 ’25. At $46.95 per share, Golden Lee Scott sold 897 shares. The insider’s holdings dropped to 75,997 shares worth approximately $3.25 million following the completion of this transaction.
Also, Golden Lee Scott purchased 897 shares, netting a total of over 42,117 in proceeds.
Before that, Pauwels Eric had sold 6,762 shares from its account. In a trade valued at $384,067, the CHIEF BUSINESS OFFICER traded PTC Therapeutics Inc shares for $56.80 each. Upon closing the transaction, the insider’s holdings decreased to 6,762 shares, worth approximately $3.11 million.
As published in a research note from BofA Securities on March 11, 2025, PTC Therapeutics Inc [PTCT] has been rated up from an Underperform to a Neutral and the price target has been revised to $55 from $41. Analysts at Scotiabank started covering the stock with ‘”a Sector perform”‘ outlook in a report released in early March. As of December 13, 2024, Morgan Stanley has increased its “an Equal-weight” rating to a “an Overweight” for PTCT. Earlier on December 03, 2024, RBC Capital Mkts upgraded its rating. Their new recommendation was “an Outperform” for PTCT stock which previously was a “a Sector perform”.
Analyzing PTCT Stock Performance
During the last five days, there has been a drop of approximately -11.62%. Over the course of the year, PTC Therapeutics Inc shares have dropped approximately -5.29%. Shares of the company reached a 52-week high of $58.38 on 03/17/25 and a 52-week low of $37.32 on 04/09/25. A 50-day SMA is recorded $50.87, while a 200-day SMA reached $41.79.
Support And Resistance Levels for PTC Therapeutics Inc (PTCT)
According to the 24-hour chart, there is a support level at 38.69, which, if violated, would cause prices to drop to 34.63. In the upper region, resistance lies at 45.44. The next price resistance is at 48.13. RSI (Relative Strength Index) is 33.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -7.95, which suggests the price will decrease in the coming days. Percent R is at 73.70%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
